Suppliers / Lactose (India)

Lactose (India)

India 2 duplicate records merged Updated 9 July 2026

Lactose (India) is an API manufacturer based in India. It holds one active US drug master file and one valid CEP. Its filings concentrate with NAFDAC (NG), MINSA (CR) and UZPHARM (UZ). Its GMP standing is certified by CDSCO (India), NAFDAC (NG) and EAEU_EEC. Customs aggregates show $3.4M of exports covering 46 molecules to 9 destinations in 2025.

1
active US DMFs
1
valid CEPs
5
registered plants 1 with an FDA FEI number
5
filings across 3 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
EU GMP
0 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Registered plants

Site FDA FEI
e poicha rania tal savli poicha vadodara, India Not on file
Vadodara, India 3014659521
Mumbai, India Not on file
a rania tal savlipoichavadoda ra 391 780, India Not on file
RICT -VADODARA, Nigeria Not on file

What they file, and where

Molecule Regulators Docs
Lactulose EDQM, US FDA 2

Also appears on these molecule pages

Filings and GMP by regulator

Regulator Filings GMP certificates
NAFDAC (NG) 3 2
MINSA (CR) 1 None
UZPHARM (UZ) 1 None
CDSCO (India) None 3
EAEU_EEC None 1

Scale

Year Revenue Exports Destinations
2026 YTD Not reported $331K 3
2025 Not reported $3.4M 9
2024 Not reported $1.2M 7
2023 Not reported $1.5M 7

Export figures are customs aggregates. We do not publish the identity of any buyer.

Comparing suppliers?

Choose your molecules and target markets. Lactose (India) comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates
Customs aggregates
Export values, molecule and destination counts